SUPN
SUPERNUS PHARMACEUTICALS, INC. · Healthcare · Market cap $2.4B
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$10.3M
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Latest filing
Aug 14, 2026
Bhatt Padmanabh P.
SUPERNUS PHARMACEUTICALS, INC. (SUPN) has 30 SEC Form 4 filings (98 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Aug 14, 2026.
Inside the rolling window, 7 insiders at SUPERNUS PHARMACEUTICALS, INC. reported no open-market purchases and 13 open-market sales totaling $10.3M. The most active filer is Sr. VP of IP, CSO Bhatt Padmanabh P. with 4 filings. Insiders have net sold $9.2M over the trailing 6 months. The most recent open-market filing is a sale of 50,000 shares by Sr. VP of IP, CSO Bhatt Padmanabh P., dated Mar 16, 2026, worth $2.5M.
- Industry:Drug Manufacturers - Specialty & Generic
- CEO:Jack A. Khattar
- Employees:778
- HQ:Rockville, MD, US
- IPO:2012-05-01
| Source | |||||||
|---|---|---|---|---|---|---|---|
| Sr. VP of IP, CSO | Sale | 50,000 | $2.5M | Mar 18 | -16.4% | SEC ↗ | |
| Sr. VP of IP, CSO | Sale | 50,000 | $2.5M | Mar 18 | -16.4% | SEC ↗ | |
| Sr. VP of IP, CSO | Sale | 7,250 | $360K | Mar 18 | -16.4% | SEC ↗ | |
Khattar Jack A.First filing | President, CEO | Sale | 35,000 | $1.8M | Mar 16 | -17.9% | SEC ↗ |
Hudson Frederick M.First filing | Director | Sale | 5,369 | $272K | Mar 16 | -17.9% | SEC ↗ |
Horich William ToddFirst filing | SVP, Commercial Operations | Sale | 4,438 | $240K | Mar 10 | — | SEC ↗ |
Horich William ToddFirst filing | SVP, Commercial Operations | Sale | 4,439 | $244K | Mar 10 | — | SEC ↗ |
| SVP, Chief Tech. Ops. Officer | Sale | 1,623 | $87K | Mar 10 | — | SEC ↗ | |
GEMAYEL GEORGESFirst filing | Director | Sale | 10,000 | $537K | Mar 9 | — | SEC ↗ |
GEMAYEL GEORGESFirst filing | Director | Sale | 8,787 | $466K | Mar 9 | — | SEC ↗ |
Sensenig BethanyFirst filing | Director | Sale | 4,475 | $228K | Feb 23 | — | SEC ↗ |
Mottola FrankFirst filing | SVP, Chief Tech. Ops. Officer | Sale | 20,000 | $1.0M | Dec 22 | — | SEC ↗ |
Bhatt Padmanabh P.First filing | Sr. VP of IP, CSO | Sale | 710 | $32K | Dec 19 | — | SEC ↗ |
Earnings: last 7 quarters
Congress trading SUPN 8 all-time
- DRep. Gilbert Ray CisnerosPurchase$1,001 - $15,0002025-12-11
- DRep. Gilbert Ray CisnerosOther$1,001 - $15,0002025-10-09
- DRep. Gilbert Ray CisnerosPurchase$1,001 - $15,0002025-03-24
- DRep. Josh S. GottheimerOther$1,001 - $15,0002022-12-23
- DRep. Gilbert Ray CisnerosPurchase$1,001 - $15,0002020-11-13
- DRep. Gilbert Ray CisnerosPurchase$1,001 - $15,0002020-07-17
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Frequently asked questions
How many SEC Form 4 insider filings does SUPN have?
SUPERNUS PHARMACEUTICALS, INC. (SUPN) has 30 SEC Form 4 filings (98 transaction rows) in the rolling 365-day window, disclosed by 7 distinct insiders. Most recent filing: Aug 14, 2026.
When was the most recent SEC Form 4 filing for SUPN?
The most recent Form 4 filing for SUPN on Tracefour is dated Aug 14, 2026.
Who is the most active insider at SUPN?
The most active SEC Form 4 filer at SUPN in the rolling window is Sr. VP of IP, CSO Bhatt Padmanabh P., with 4 filings.
What is the net insider flow at SUPN over the last 6 months?
Over the trailing 180 days, insiders at SUPN have net sold $9.2M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at SUPN in the current window?
Inside the rolling window, insiders at SUPN bought $0 and sold $10.3M based on SEC Form 4 filings.
Can I get alerts for SUPN insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at SUPERNUS PHARMACEUTICALS, INC. (SUPN). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
SUPERNUS PHARMACEUTICALS, INC. is in the Healthcare sector.